Delivery Order SPE2DB20D1100-SPE2DB25FE1ED
Award Date 9/25/25
Potential Completion Date 9/26/25
Potential Value $4.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency's Medical Supply Chain for Multaq 400 mg tablets (60-count units) valued at $4,589.64. The contract, awarded on August 1, 2025, with an ultimate completion date of August 4, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. This award represents a competitively awarded transaction under...
- The Defense Logistics Agency awarded a $4,824.44 delivery order to AmerisourceBergen Drug Corp for MULTAQ 400 mg tablets (60 count) on September 3, 2025, with an ultimate completion date of September 4, 2025. This is a firm fixed-price, non-set-aside contract performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The delivery order represents a child contract action under the company's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $2,422.22 by the Defense Logistics Agency on July 14, 2025, for the supply of Multaq 400 mg tablets (60-count units). The contract is classified as a firm fixed price delivery order with an ultimate completion date of July 15, 2025, and carries no set-aside designation, indicating it was competitively awarded. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $7,181.52 for 60 tablets of MULTAQ 400 mg on August 6, 2025, with completion scheduled for August 7, 2025. This firm fixed-price, non-set-aside contract represents a single delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The delivery order will be performed at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for MULTAQ (dronedarone) 400 mg tablets, quantity 60, valued at $16,743.54 under a firm fixed-price contract with an ultimate completion date of August 15, 2025. This non-set-aside award represents a single delivery order placed against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999.99 million through December 2026. The product...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on June 9, 2025, for the supply of MULTAQ 400 mg tablets (60-count packages) under a firm fixed-price contract. The award, valued at $4,604.72, represents a non-set-aside competitive award with an ultimate completion date of June 10, 2025. This delivery order is a child contract executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a delivery order award from the Defense Logistics Agency for MULTAQ 400 mg tablets (60-count units) valued at $1,569.84. The award, issued on September 3, 2025, represents a firm fixed-price delivery order with an ultimate completion date of September 4, 2025. This is a competitively awarded contract with no set-aside designation, reflecting AmerisourceBergen's demonstrated...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for MULTAQ 400 MG tablets (60-count units) on June 16, 2025, with an ultimate completion date of June 17, 2025. This contract, valued at $9,756.31, utilizes firm fixed price terms and was awarded without a set-aside designation through competitive procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $11,497.10 firm fixed price delivery order by the Defense Department's Medical Supply Chain on September 12, 2025, for 60 tablets of Multaq 400mg. The award was made competitively with no set-aside designation and has an ultimate completion date of October 9, 2025. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for MULTAQ 400 mg tablets (60-count) under a firm fixed-price contract valued at $3,059.76. The order was competitively awarded without set-aside designation and is scheduled for completion by July 22, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will fulfill this pharmaceutical delivery from its corporate office location. This delivery order is issued under AmerisourceBergen's larger...